GlucoTrack

Youtube Subscribe

Ticker: GCTK

Sector: Medical Instruments & Supplies

GlucoTrack

GlucoTrack aims to develop a continuous glucose monitor device with a long sensor life, no additional wearable component, and a once-only calibration event. New Jersey-based company has completed the first preclinical study with its implantable continuous glucose monitoring device (CBGM) The company has a debt-to-equity ratio. US-based medical device company GlucoTrack has reported positive early accuracy data from the first preclinical study of its implantable continuous blood glucose monitor (CBGM) The trial was intended to evaluate implant technique and CBGMs safety.